These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 35255343)
21. Determination of antibacterial activity and minimum inhibitory concentration of larval extract of fly via resazurin-based turbidometric assay. Teh CH; Nazni WA; Nurulhusna AH; Norazah A; Lee HL BMC Microbiol; 2017 Feb; 17(1):36. PubMed ID: 28209130 [TBL] [Abstract][Full Text] [Related]
22. In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species. Marchese A; Salerno A; Pesce A; Debbia EA; Schito GC Chemotherapy; 2000; 46(4):253-66. PubMed ID: 10859431 [TBL] [Abstract][Full Text] [Related]
23. Studies on the development and stability of resistance of Helicobacter pylori to metronidazole and clarithromycin. Baffone W; Pianetti A; Citterio B; Lombardelli G; Vittoria E; Bruscolini F J Chemother; 2001 Apr; 13(2):126-32. PubMed ID: 11330358 [TBL] [Abstract][Full Text] [Related]
24. Rational Design of Dimeric Lysine N-Alkylamides as Potent and Broad-Spectrum Antibacterial Agents. Niu Y; Wang M; Cao Y; Nimmagadda A; Hu J; Wu Y; Cai J; Ye XS J Med Chem; 2018 Apr; 61(7):2865-2874. PubMed ID: 29569910 [TBL] [Abstract][Full Text] [Related]
25. Potent bactericidal constituents from Mallotus philippinensis against clarithromycin and metronidazole resistant strains of Japanese and Pakistani Helicobacter pylori. Zaidi SF; Yoshida I; Butt F; Yusuf MA; Usmanghani K; Kadowaki M; Sugiyama T Biol Pharm Bull; 2009 Apr; 32(4):631-6. PubMed ID: 19336896 [TBL] [Abstract][Full Text] [Related]
26. Association of metronidazole resistance and natural competence in Helicobacter pylori. Yeh YC; Chang KC; Yang JC; Fang CT; Wang JT Antimicrob Agents Chemother; 2002 May; 46(5):1564-7. PubMed ID: 11959600 [TBL] [Abstract][Full Text] [Related]
27. Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole. Larsen T Oral Microbiol Immunol; 2002 Oct; 17(5):267-71. PubMed ID: 12354206 [TBL] [Abstract][Full Text] [Related]
28. The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus. Kim W; Zou G; Pan W; Fricke N; Faizi HA; Kim SM; Khader R; Li S; Lee K; Escorba I; Vlahovska PM; Gao H; Ausubel FM; Mylonakis E mBio; 2020 Jun; 11(3):. PubMed ID: 32605985 [TBL] [Abstract][Full Text] [Related]
29. In vitro bactericidal activity of piperacillin, gentamicin, and metronidazole in a mixed model containing Escherichia coli, Enterococcus faecalis, and Bacteroides fragilis. Pendland SL; Jung R; Messick CR; Schriever CA; Patka J Diagn Microbiol Infect Dis; 2002 Jun; 43(2):149-56. PubMed ID: 12088623 [TBL] [Abstract][Full Text] [Related]
30. In vitro anti-Helicobacter pylori activity of BAS-118, a new benzamide derivative. Kobayashi I; Muraoka H; Hasegawa M; Saika T; Nishida M; Kawamura M; Ando R J Antimicrob Chemother; 2002 Jul; 50(1):129-32. PubMed ID: 12096019 [TBL] [Abstract][Full Text] [Related]
31. [Prevalence of Helicobacter pylori resistant to clarithromycin, amoxicillin and metronidazole in children]. Chen J; Chen FB; Yu JD; Chen XJ; Li ZY; Zhang XP Zhonghua Er Ke Za Zhi; 2004 Oct; 42(10):769-71. PubMed ID: 16221349 [TBL] [Abstract][Full Text] [Related]
32. Mechanisms of Bacteroides fragilis resistance to metronidazole. Ghotaslou R; Bannazadeh Baghi H; Alizadeh N; Yekani M; Arbabi S; Memar MY Infect Genet Evol; 2018 Oct; 64():156-163. PubMed ID: 29936037 [TBL] [Abstract][Full Text] [Related]
33. Antibacterial activity of colloidal copper nanoparticles against Gram-negative (Escherichia coli and Proteus vulgaris) bacteria. Sharma P; Goyal D; Chudasama B Lett Appl Microbiol; 2022 May; 74(5):695-706. PubMed ID: 35034356 [TBL] [Abstract][Full Text] [Related]
34. Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication. De Francesco V; Zullo A; Fiorini G; Saracino IM; Pavoni M; Vaira D J Antimicrob Chemother; 2019 Mar; 74(3):772-774. PubMed ID: 30476134 [TBL] [Abstract][Full Text] [Related]
35. Design of Heptad Repeat Amphiphiles Based on Database Filtering and Structure-Function Relationships to Combat Drug-Resistant Fungi and Biofilms. Tan P; Lai Z; Jian Q; Shao C; Zhu Y; Li G; Shan A ACS Appl Mater Interfaces; 2020 Jan; 12(2):2129-2144. PubMed ID: 31887002 [TBL] [Abstract][Full Text] [Related]
36. Design and biological evaluation of novel quinolone-based metronidazole derivatives as potent Cu(2+) mediated DNA-targeting antibacterial agents. Zhang L; Kumar KV; Geng RX; Zhou CH Bioorg Med Chem Lett; 2015 Sep; 25(17):3699-705. PubMed ID: 26149183 [TBL] [Abstract][Full Text] [Related]
37. Antibacterial activity of teicoplanin against Clostridium difficile. Wongwanich S; Kusum M; Phan-Urai R Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):606-9. PubMed ID: 9185278 [TBL] [Abstract][Full Text] [Related]
38. Analysis of the rdxA gene in high-level metronidazole-resistant clinical isolates confirms a limited use of rdxA mutations as a marker for prediction of metronidazole resistance in Helicobacter pylori. Bereswill S; Krainick C; Stähler F; Herrmann L; Kist M FEMS Immunol Med Microbiol; 2003 May; 36(3):193-8. PubMed ID: 12738391 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and bioactivities of new N-terminal dipeptide mimetics with aromatic amide moiety: Broad-spectrum antibacterial activity and high antineoplastic activity. Li H; Fu S; Liu L; Yuan X; Wang Y; Zhang C; Dong H; Satoh T Eur J Med Chem; 2022 Jan; 228():113977. PubMed ID: 34772526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]